{"id":"https://openalex.org/W7214276776","doi":"https://doi.org/10.64898/2026.09.19.752834","title":"De novo design of protease-activatable cytokine prodrugs","display_name":"De novo design of protease-activatable cytokine prodrugs","publication_year":2026,"publication_date":"2026-09-22","ids":{"openalex":"https://openalex.org/W7214276776","doi":"https://doi.org/10.64898/2026.09.19.752834","pmid":"https://pubmed.ncbi.nlm.nih.gov/42818144","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13622076"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.19.752834","doi":"https://doi.org/10.64898/2026.09.19.752834","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.19.752834","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/22/2026.09.19.752834.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/22/2026.09.19.752834.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057838240","display_name":"Hojeong Shin","orcid":"https://orcid.org/0000-0001-5895-0955","observed_orcids":["https://orcid.org/0000-0001-5895-0955"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hojeong Shin","raw_affiliation_strings":["Department of Biochemistry, University of Washington, Seattle, WA, USA","Institute for Protein Design, University of Washington, Seattle, WA, USA"],"raw_orcid":"https://orcid.org/0000-0001-5895-0955","affiliations":[{"raw_affiliation_string":"Department of Biochemistry, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Institute for Protein Design, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120822800","display_name":"Julissa G. Tello","orcid":"https://orcid.org/0009-0009-7866-7327","observed_orcids":["https://orcid.org/0009-0009-7866-7327"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julissa G. Tello","raw_affiliation_strings":["Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083581120","display_name":"Chan Johng Kim","orcid":"https://orcid.org/0000-0002-7256-0205","observed_orcids":["https://orcid.org/0000-0002-7256-0205"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chan Johng Kim","raw_affiliation_strings":["Department of Biochemistry, University of Washington, Seattle, WA, USA","Institute for Protein Design, University of Washington, Seattle, WA, USA"],"raw_orcid":"https://orcid.org/0000-0002-7256-0205","affiliations":[{"raw_affiliation_string":"Department of Biochemistry, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Institute for Protein Design, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152930943","display_name":"Jung-Ho Chun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jung-Ho Chun","raw_affiliation_strings":["Department of Biochemistry, University of Washington, Seattle, WA, USA","Institute for Protein Design, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Institute for Protein Design, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119738442","display_name":"Frank Peprah","orcid":"https://orcid.org/0009-0004-6213-487X","observed_orcids":["https://orcid.org/0009-0004-6213-487X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Peprah","raw_affiliation_strings":["Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006837949","display_name":"Brendan D. Parent","orcid":"https://orcid.org/0009-0001-8258-1755","observed_orcids":["https://orcid.org/0009-0001-8258-1755"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brendan D. Parent","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092821605","display_name":"Tavus Atajanova","orcid":"https://orcid.org/0009-0000-3811-778X","observed_orcids":["https://orcid.org/0009-0000-3811-778X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tavus Atajanova","raw_affiliation_strings":["Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152951026","display_name":"Robiah Arefin Ibn Mahmud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robiah Arefin Ibn Mahmud","raw_affiliation_strings":["Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152908284","display_name":"Li Qiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Qiang","raw_affiliation_strings":["Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Immunology, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Immunology, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079764447","display_name":"Andrew J. Aguirre","orcid":"https://orcid.org/0000-0002-0701-6203","observed_orcids":["https://orcid.org/0000-0002-0701-6203"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Aguirre","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Medicine, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001285437","display_name":"Stephanie K. Dougan","orcid":"https://orcid.org/0000-0002-2263-363X","observed_orcids":["https://orcid.org/0000-0002-2263-363X","https://orcid.org/0000-0001-7667-5491"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephanie K. Dougan","raw_affiliation_strings":["Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Immunology, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Immunology, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043698578","display_name":"Michael Lawrence Dougan","orcid":"https://orcid.org/0000-0001-9266-2009","observed_orcids":["https://orcid.org/0000-0001-9266-2009"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Dougan","raw_affiliation_strings":["Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Medicine, Harvard Medical School, Boston, MA, USA","Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053192926","display_name":"David A. Baker","orcid":"https://orcid.org/0000-0001-7896-6217","observed_orcids":["https://orcid.org/0000-0001-7896-6217"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Baker","raw_affiliation_strings":["Department of Biochemistry, University of Washington, Seattle, WA, USA","Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA","Institute for Protein Design, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I1344073410","https://openalex.org/I201448701"]},{"raw_affiliation_string":"Institute for Protein Design, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5001285437","https://openalex.org/A5043698578","https://openalex.org/A5053192926"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I1344073410","https://openalex.org/I136199984","https://openalex.org/I201448701","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.15139999985694885,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.15139999985694885,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13326","display_name":"Biochemical and Structural Characterization","score":0.1404000073671341,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.11789999902248383,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/de-novo-protein-design","display_name":"de novo protein design","score":0.9620000123977661},{"id":"https://openalex.org/keywords/il-21","display_name":"IL-21","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tumor-associated-proteases","display_name":"tumor-associated proteases","score":0.7350000143051147},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.7110000252723694},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.8999000191688538},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.7534999847412109},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5595999956130981},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.4616999924182892},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4277999997138977},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.390500009059906},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3400999903678894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33320000767707825},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.32100000977516174},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.31369999051094055},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2935999929904938},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.290800005197525},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27869999408721924},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2718000113964081},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2689000070095062},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.26159998774528503},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.2549999952316284},{"id":"https://openalex.org/C2777402240","wikidata":"https://www.wikidata.org/wiki/Q6783436","display_name":"Masking (illustration)","level":2,"score":0.2513999938964844}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.64898/2026.09.19.752834","doi":"https://doi.org/10.64898/2026.09.19.752834","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.19.752834","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/22/2026.09.19.752834.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmid:42818144","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42818144","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"bioRxiv : the preprint server for biology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13622076","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13622076/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"bioRxiv","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.64898/2026.09.19.752834","doi":"https://doi.org/10.64898/2026.09.19.752834","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.19.752834","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/22/2026.09.19.752834.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1612711268","display_name":"Design of de novo interleukin mimics for targeted immunotherapy","funder_award_id":"R01CA240339","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2038951588","display_name":null,"funder_award_id":"U01 CA274276","funder_id":"https://openalex.org/F4320316669","funder_display_name":"Break Through Cancer"},{"id":"https://openalex.org/G3780184621","display_name":"MATCHMAKERS","funder_award_id":"OT2CA297288","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4726734171","display_name":null,"funder_award_id":"CGCATF-2023/100008","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8686771678","display_name":null,"funder_award_id":"R0AI160052","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000857955","display_name":"Signaling pathways in tumoricidal macrophages in pancreatic cancer","funder_award_id":"K99CA293136","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000858781","display_name":"Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity","funder_award_id":"U01CA274276","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000887975","display_name":"CDK4/6 inhibition during CD8 T cell priming potentiates memory formation in mice and humans","funder_award_id":"R01AI158488","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000903027","display_name":"Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut","funder_award_id":"R01AI169188","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000917150","display_name":"De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics","funder_award_id":"R01AI160052","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320306854","display_name":"Washington Research Foundation","ror":"https://ror.org/00hasdx88"},{"id":"https://openalex.org/F4320312209","display_name":"Barr Foundation","ror":"https://ror.org/053gvz184"},{"id":"https://openalex.org/F4320315119","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02"},{"id":"https://openalex.org/F4320316669","display_name":"Break Through Cancer","ror":"https://ror.org/00a8me616"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320333947","display_name":"Ludwig Center at Harvard","ror":null},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214276776.pdf","grobid_xml":"https://content.openalex.org/works/W7214276776.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1555862556","https://openalex.org/W1997104566","https://openalex.org/W2005334224","https://openalex.org/W2022223794","https://openalex.org/W2106071154","https://openalex.org/W2163926878","https://openalex.org/W2321372058","https://openalex.org/W2623288415","https://openalex.org/W2788587230","https://openalex.org/W2900046418","https://openalex.org/W2908391177","https://openalex.org/W2923305484","https://openalex.org/W3004471226","https://openalex.org/W3023998523","https://openalex.org/W3028847539","https://openalex.org/W3163035768","https://openalex.org/W3185291504","https://openalex.org/W4205372958","https://openalex.org/W4205683421","https://openalex.org/W4206952776","https://openalex.org/W4210429334","https://openalex.org/W4212946280","https://openalex.org/W4220767421","https://openalex.org/W4229452725","https://openalex.org/W4296032638","https://openalex.org/W4296078133","https://openalex.org/W4307715650","https://openalex.org/W4375856225","https://openalex.org/W4389154391","https://openalex.org/W4399662709","https://openalex.org/W4400867712","https://openalex.org/W4405319353","https://openalex.org/W4414535535","https://openalex.org/W4416955829"],"related_works":["https://openalex.org/W3212296140","https://openalex.org/W3163035768","https://openalex.org/W3177799967","https://openalex.org/W3213880233","https://openalex.org/W4412779897","https://openalex.org/W1561744531","https://openalex.org/W43798243","https://openalex.org/W4282944927","https://openalex.org/W4415898694","https://openalex.org/W1503334214"],"abstract_inverted_index":{"Cytokines":[0],"can":[1],"elicit":[2],"potent":[3],"antitumor":[4,101],"immunity,":[5],"but":[6,36],"their":[7],"clinical":[8],"use":[9,62],"is":[10],"often":[11],"limited":[12],"by":[13,28],"systemic":[14],"immune":[15],"activation":[16],"and":[17,67,71,81],"dose-limiting":[18],"toxicity.":[19],"Protease-responsive":[20],"masking":[21],"offers":[22],"a":[23,46],"way":[24],"to":[25,32,65,84],"improve":[26],"selectivity":[27],"linking":[29],"cytokine":[30,55,69],"activity":[31],"disease-associated":[33],"protease":[34],"cleavage,":[35],"current":[37],"approaches":[38],"have":[39],"faced":[40],"several":[41],"challenges.":[42,60],"Here":[43],"we":[44],"describe":[45],"de":[47],"novo":[48],"protein":[49],"design":[50,66],"strategy":[51,64],"for":[52],"generating":[53],"protease-activatable":[54],"prodrugs":[56,70,95],"that":[57,76],"overcomes":[58],"these":[59],"We":[61],"this":[63],"characterize":[68],"well-behaved":[72],"AND-gated":[73],"split":[74],"systems":[75],"require":[77],"both":[78],"target-dependent":[79],"colocalization":[80],"proteolytic":[82],"unmasking":[83],"generate":[85],"active":[86],"cytokines.":[87],"In":[88],"challenging":[89],"syngeneic":[90],"tumor":[91],"models,":[92],"our":[93],"IL-21":[94],"reduced":[96],"treatment-associated":[97],"toxicity":[98],"while":[99],"maintaining":[100],"efficacy.":[102]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-09-26T00:00:00"}